Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model

In this paper an age-structured mathematical model for respiratory syncytial virus (RSV) is proposed where children younger than one year old, who are the most affected by this illness, are specially considered. Real data of hospitalized children in the Spanish region of Valencia are used in order to determine some seasonal parameters of the model. Once the parameters are determined, we propose a complete stochastic network model to study the seasonal evolution of the respiratory syncytial virus (RSV) epidemics. In this model every susceptible individual can acquire the disease after a random encounter with any infected individual in the social network. The edges of a complete graph connecting every pair of individuals in the network simulate these encounters and a season dependent probability, @b(t), determines whether the healthy susceptible individual becomes infected or not. We show that the prediction of this model is compatible with the above mentioned age-structured model based upon differential equations, but sharper peaks are obtained in the case of the network. Then, on the network model, we propose the vaccination of children at 2 months, 4 months and 1 year old, and we study the cost of this vaccination strategy, which is emerging as the most plausible one to be applied when the vaccine hits the market. It is worth to note that this vaccination strategy is simulated in the network model because to implement it in the continuous model is very difficult and increases its complexity.

[1]  Herbert W. Hethcote,et al.  The Mathematics of Infectious Diseases , 2000, SIAM Rev..

[2]  A. Weber,et al.  Modeling epidemics caused by respiratory syncytial virus (RSV). , 2001, Mathematical biosciences.

[3]  N. E. Babady,et al.  Respiratory Syncytial Virus and Human Metapneumovirus , 2011 .

[4]  N. Rashevsky,et al.  Mathematical biology , 1961, Connecticut medicine.

[5]  P. Cane,et al.  Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models , 2007, Mathematical biosciences.

[6]  R. Feigin,et al.  Textbook of Pediatric Infectious Diseases , 1986 .

[7]  R. Walker,et al.  Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults. , 2008, Vaccine.

[8]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[9]  Leah Edelstein-Keshet,et al.  Mathematical models in biology , 2005, Classics in applied mathematics.

[10]  A. Nizam,et al.  Containing Bioterrorist Smallpox , 2002, Science.

[11]  F. Brauer,et al.  Mathematical Models in Population Biology and Epidemiology , 2001 .

[12]  Luis Acedo,et al.  A second-order phase transition in the complete graph stochastic epidemic model , 2006 .

[13]  W. Press,et al.  Numerical Recipes: The Art of Scientific Computing , 1987 .

[14]  W. O. Kermack,et al.  Contributions to the mathematical theory of epidemics—I , 1991, Bulletin of mathematical biology.

[15]  D. Mollison Epidemic models : their structure and relation to data , 1996 .

[16]  J. Díez Domingo,et al.  Incidencia y costes de la hospitalización por bronquiolitis y de las infecciones , 2006 .

[17]  Payal Kapur,et al.  Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. , 2004, The Journal of infectious diseases.

[18]  R. Villanueva,et al.  Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications , 2009, Epidemiology and Infection.

[19]  S. Bayliss,et al.  Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation. , 2008, Health technology assessment.

[20]  J. Koopman,et al.  Controlling Smallpox , 2002, Science.